Introduction {#Sec1}
============

Large spectrum antibiotics have to be considered as first treatment of infection in ICU patients.

Objectives {#Sec2}
==========

To evaluate the antibiotic treatments in ICU patients and to compare treatments on admission and during ICU stay.

Methods {#Sec3}
=======

A Six-month prospective study in 5 ICUs of a hospital totalizing 44 ICU beds. Antibiotic treatments were divided in three groups: treatment started before ICU admission (1), treatments started the day of ICU admission (2) and treatments initiated during ICU stay (3). The type of beta-lactam antibiotics (BA) used was listed at the start of treatment and after 3 days.

Results {#Sec4}
=======

459 treatments given to 363 patients among 1131 hospitalized patients were analyzed. There were respectively 131, 167 and 161 treatments in group 1, 2 and 3. After 3 days, 79 (17.2%) treatments could be stopped because of no infections and 129 (28.1%) were changed mostly for streamlining. Table [1](#Tab1){ref-type="table"} shows the number of treatment with BA according to groups and to the time of treatment.Table 1Type of BABefore admission (group 1)On admission (group 2)During ICU stay (group 3)After 3 days n = 96 (group 1)After 3 days n = 133 (group 2)After 3days n = 148 (group 3)Ampicilline- Amoxicilline - Temocilline2 (1,5%)2 (1,2%)3 (1,9%)4 (4,2%)9 (6,8%)10 (6,8%)Penicillin1 (0,8%)1 (0,6%)0 (0%)1 (1%)4 (3%)0 (0%)Flucloxacillin8 (6%)0 (0%)10 (6%)11 (11,5%)5 (3,8%)11 (6,8%)Amoxi-Clav15 (11,5%)35 (21%)15 (9,3%)1 (1%)13 (9,8%)7 (4,7%)Pipera-Tazo42 (32,1%)54 (32,3%)32 (19,9%)17 (17,7%)21 (15,8%)13 (8,8%)Cephal 2G3 (2,3%)5 (3%)9 (5,6%)8 (8,3%)11 (8,3%)15 (10,1%)Cephal 3G14 (10,7%)34 (20,4%)35 (21,7%)19 (19,8%)20 (15%)26 (17,6%)Cephal 4G7 (5,3%)1 (0,6%)2 (1,2%)2 (2,1%)1 (0,8%)1 (0,7%)Carbapenem17 (13%)15 (8,9%)19 (11,8%)10 (10,4%)12 (9%)14 (9,5%)

There was a tendency to use less BA during ICU stay, the difference was significant only at the start of treatment (p = 0.027). If we consider ampicillin, temocillin, penicillin, flucloxacillin and 2nd -generation cephalosporin as molecule with narrow spectrum of activity, these molecules were significantly more used after three days of treatment (p \< 0.0001). Interestingly this difference already existed at the start of treatment when group 3 was compared to the two others (p = 0.0159). Among the 459 treatments, there were, in 49 patients, 51 inappropriate treatments according to the bacteriological results, 16 (12%) in group 1, 17 (10%) in group 2 and 18 (11%) in group 3 (p = 0.857). The ICU mortality was not different between those patients (11/49 = 22%) and the others (77/314 = 24.5%) (p = 0859).

Conclusions {#Sec5}
===========

Beta-lactam antibiotics remain the cornerstone of antibacterial therapy. A cautious strategy with narrow spectrum beta-lactam antibiotics could be supported in ICU patients when possible.Table 2TOTAL109 (83,2%)147 (88%)125 (77,6%)73 (76%)96 (72,2%)97 (65,5%)
